Aggressive and recurrent ovarian cancers upregulate ephrinA5, a non-canonical effector of EphA2 signaling duality
Abstract Erythropoietin producing hepatocellular (Eph) receptors and their membrane-bound ligands ephrins are variably expressed in epithelial cancers, with context-dependent implications to both tumor-promoting and -suppressive processes in ways that remain incompletely understood. Using ovarian ca...
Guardado en:
Autores principales: | Joonas Jukonen, Lidia Moyano-Galceran, Katrin Höpfner, Elina A. Pietilä, Laura Lehtinen, Kaisa Huhtinen, Erika Gucciardo, Johanna Hynninen, Sakari Hietanen, Seija Grénman, Päivi M. Ojala, Olli Carpén, Kaisa Lehti |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ecaf312fb199488291cd2a4acc2a122b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Human herpesvirus 8 molecular mimicry of ephrin ligands facilitates cell entry and triggers EphA2 signaling.
por: Taylor P Light, et al.
Publicado: (2021) -
Design and evaluation of EphrinA1 mutants with cerebral protective effect
por: Yuanjun Zhu, et al.
Publicado: (2017) -
EphrinA1-targeted nanoshells for photothermal ablation of prostate cancer cells
por: Andre M Gobin, et al.
Publicado: (2008) -
Co-evolution of matrisome and adaptive adhesion dynamics drives ovarian cancer chemoresistance
por: Elina A. Pietilä, et al.
Publicado: (2021) -
Cytoplasmic relaxation of active Eph controls ephrin shedding by ADAM10.
por: Peter W Janes, et al.
Publicado: (2009)